166 related articles for article (PubMed ID: 35675040)
1. Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China.
Yin Z; Wen T; Fang Q; Zheng C; Gong X; Li J; Wang S; Xiang Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2086774. PubMed ID: 35675040
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China.
Zhou C; Song W; Yin Z; Li S; Gong X; Fang Q; Wang S
J Immunol Res; 2020; 2020():8130760. PubMed ID: 32300606
[TBL] [Abstract][Full Text] [Related]
3. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.
Ma C; Liu Y; Tang J; Jia H; Qin W; Su Y; Wang H; Hao L
Hum Vaccin Immunother; 2018 Jun; 14(6):1392-1397. PubMed ID: 29377772
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation on the short term effectiveness of two doses mumps-containing vaccine policy in Shandong, China].
Xu Q; Xiong P; Fang XQ; Liu XD; Wang CY; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):265-270. PubMed ID: 29973005
[No Abstract] [Full Text] [Related]
5. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.
Wang D; Nie T; Pan F; Wang Y; Wang J; Qin W
Hum Vaccin Immunother; 2021 Jul; 17(7):2072-2077. PubMed ID: 33545016
[No Abstract] [Full Text] [Related]
6. Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model.
Yin Z; Zheng C; Fang Q; Gong X; Cao G; Li J; Xiang Z; Song W
J Immunol Res; 2021; 2021():5990417. PubMed ID: 34778466
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination.
Qin W; Wang Y; Yang T; Xu XK; Meng XM; Zhao CJ; Li SY; Xie SY; Li KC; Su H
Hum Vaccin Immunother; 2019; 15(9):2106-2111. PubMed ID: 30779678
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
[TBL] [Abstract][Full Text] [Related]
9. Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China.
Li D; Zhang H; You N; Chen Z; Yang X; Zhang H; Zhou Y; Zheng N; Pan W
Hum Vaccin Immunother; 2022 Nov; 18(6):2096375. PubMed ID: 35950847
[TBL] [Abstract][Full Text] [Related]
10. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.
Ma R; Lu L; Zhou T; Pan J; Chen M; Pang X
Vaccine; 2018 May; 36(19):2589-2595. PubMed ID: 29653850
[TBL] [Abstract][Full Text] [Related]
11. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
12. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
13. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for measles, mumps and rubella in children.
Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
[TBL] [Abstract][Full Text] [Related]
15. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.
Deeks SL; Lim GH; Simpson MA; Gagné L; Gubbay J; Kristjanson E; Fung C; Crowcroft NS
CMAJ; 2011 Jun; 183(9):1014-20. PubMed ID: 21576295
[TBL] [Abstract][Full Text] [Related]
16. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.
Woudenberg T; van der Maas NAT; Knol MJ; de Melker H; van Binnendijk RS; Hahné SJM
J Infect Dis; 2017 Apr; 215(8):1181-1187. PubMed ID: 28368471
[TBL] [Abstract][Full Text] [Related]
19. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
[TBL] [Abstract][Full Text] [Related]
20. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
